UPLOAD Filing
InMed Pharmaceuticals Inc.
Date: July 14, 2025 · CIK: 0001728328 · Accession: 0000000000-25-007366
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288594
Letter
Re: InMed Pharmaceuticals Inc. Registration Statement on Form S-1 Filed July 9, 2025 File No. 333-288594 Dear Eric Adams:
July 14, 2025
Eric Adams Chief Executive Officer InMed Pharmaceuticals Inc. Suite 1445 885 West Georgia St. Vancouver, British Columbia, Canada V6C 3E8
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Scott Saks, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 14, 2025 Eric Adams Chief Executive Officer InMed Pharmaceuticals Inc. Suite 1445 885 West Georgia St. Vancouver, British Columbia, Canada V6C 3E8 Re: InMed Pharmaceuticals Inc. Registration Statement on Form S-1 Filed July 9, 2025 File No. 333-288594 Dear Eric Adams: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Scott Saks, Esq. </TEXT> </DOCUMENT>